Instrument Inactif

Autres langues Simcere Pharmaceutical Group (ADR)

Actions

US82859P1049

Produits pharmaceutiques

Cours en clôture NYSE Autres places de cotation
- ^USD	-

31/08/15	SCOR SE : nomme Nicolas Tissot au poste de "chief operating officer"	DJ
06/05/14	SCOR SE : : résultat net en hausse de 21,6% au premier trimestre	DJ

Autres langues

23/12/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Completion of Merger
19/12/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Shareholders' Approval of the Merger Agreement
22/11/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
19/11/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Extraordinary General Meeting of Shareholders
14/11/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Reports Preliminary Unaudited Third Quarter 2013 Results
01/11/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group to Announce Third Quarter 2013 Financial Results on Thursday, November 14, 2013
15/10/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Appointment of Chief Scientific Officer
28/08/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Enters Into Definitive Merger Agreement for Going Private Transaction
13/08/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2013 Results
29/07/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group to Announce Second Quarter 2013 Financial Results on Tuesday, August 13, 2013
24/06/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Sale of Equity Interest in Boda
14/06/13	Simcere Pharmaceutical Group (ADR) : Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia® SC (abatacept) in China
29/05/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Resignation of Chief Scientific Officer
27/04/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Filed 2012 Annual Report on Form 20-F
26/04/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group to Announce First Quarter 2013 Financial Results on Thursday, May 9, 2013
03/04/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces its Special Committee's Engagement of Financial Advisor
22/03/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
12/03/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces its Special Committee's Engagement of Legal Counsel
25/02/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group to Announce Fourth Quarter and Fiscal Year 2012 Financial Results on Thursday, March 7, 2013
22/01/13	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Sale of Equity Interest in Shanghai Celgen
11/11/12	Simcere Pharmaceutical Group (ADR) : Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group
01/11/12	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group to Announce Third Quarter 2012 Financial Results on Thursday, November 15, 2012
12/10/12	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Resignation of an Independent Director
13/09/12	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer
10/08/12	Simcere Pharmaceutical Group (ADR) : Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results